Evidence map›Paper›PMID 37569611›Full record

ArticleInternational journal of molecular sciences2023

ZnO-Doped Metal-Organic Frameworks Nanoparticles: Antibacterial Activity and Mechanisms.

Huiying Zheng, Biying Zhong, Qiaowen Wang, Xi Li, Jiehan Chen, Li Liu, Tiantian Liu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Huiying ZhengSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.ORCID 0009-0004-8253-4301
Biying ZhongSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Qiaowen WangSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.ORCID 0009-0008-4897-2235
Xi LiSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Jiehan ChenSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.ORCID 0000-0001-8802-7061
Li LiuSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Tiantian LiuSchool of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Guangdong Pharmaceutical University · CN

Funding

Construction program of Techniques for diagnosis and treatment of major and outbreaks of infectious diseases and Product Incubation and Transformation System in Guangzhou City (Yue Wei Han (2022) No. 3248)-Tented Respiratory Sensing and Control MicrocubeFoshan Science and Technology Innovation Project 2020001000416
6 · The paper itself

Abstract

Metal-Organic Frameworks (MOFs) offer new ideas for the design of antibacterial materials because of their antibacterial properties, high porosity and specific surface area, low toxicity and good biocompatibility compared with other nanomaterials. Herein, a novel antimicrobial nanomaterial, MIL-101(Fe)@ZnO, has been synthesized by hydrothermal synthesis and characterized by FTIR, UV-vis, ICP-OES, XRD, SEM, EDS and BET to show that the zinc ions are doped into the crystal lattice of MIL-101(Fe) to form a Fe-Zn bimetallic structure. MIL-101(Fe)@ZnO was found to be effective against a wide range of antibacterial materials including

Indexed as

Metal-Organic FrameworksNanoparticlesZinc OxideAnti-Bacterial AgentsAnti-Bacterial AgentsMetal-Organic FrameworksMIL-101Zinc Oxideantibacterial activityantibacterial mechanismmetal-organic frameworksMIL-101(Fe)ZnO

Identifiers

PMID37569611
PMCPMC10418459
OpenAlexW4385417293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.